Next Gen Multiplexing Firm Genalyte Raises $12M Series B Financing

News   Sep 27, 2012

 
Next Gen Multiplexing Firm Genalyte Raises $12M Series B Financing
 
 
 

RELATED ARTICLES

Integrated Lab-on-a-Chip Uses Smartphone to Quickly Detect Multiple Pathogens

News

A multidisciplinary group has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit in the format of a credit card.

READ MORE

Gilead Company Wins FDA Approval for CAR T Cancer Therapy for Treatment of Adult Lymphoma

News

Kite’s Yescarta™ (axicabtagene ciloleucel) becomes first CAR T therapy approved by the FDA for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.

READ MORE


 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE